Charles River Laboratories Initiates Enhanced IT Solutions For Life Sciences Customers
October 25 2006 - 9:28AM
Business Wire
(NYSE:CRL) Charles River Laboratories, a leading contract research
organization worldwide, is dramatically enhancing its technological
capabilities across its entire business. In the life sciences
industry which is driven by information, Charles River is
implementing advanced IT solutions that will harness the cumulative
power of its diversity of sites through the harmonization of data.
These enhanced solutions will yield many benefits to the Company�s
pharmaceutical, biotech academic and government customers.
Streamlined global resource planning will maintain consistent
quality and scheduling. Increased collaboration among sites will
provide customers with Charles River�s vast breadth of global
business offerings � from drug discovery through market approval.
Further, customers will find self-service access to study data,
analysis tools, reporting engines and more through the use of
customized portals. To ensure a seamless integration of these
improvements, Charles River Labs has established two global
positions that are key to this transformation. Shanna Cotti has
assumed responsibilities as Chief Technology Officer (CTO). Ms.
Cotti will be re-architecting the infrastructure, technological
environment and data integration of these global IT initiatives.
She will be responsible for the creation, communication and
dissemination of both near-term and visionary architectural
planning across Charles River Labs. Ms. Cotti brings to Charles
River an abundance of leading edge IT expertise. Prior to joining
the Company, she was a senior consultant for Microsoft Corporation,
where she led the creation and subsequent deployment of
enterprise-wide technical architecture strategies for Fortune 500
companies. She has consulted and advised on IT strategy for global
enterprises across many industries, including consumer goods,
manufacturing, and life sciences, where she has led the
architecture and deployment of global information management and
collaboration systems. Ms. Cotti is a Pennsylvania State University
graduate of The Behrend College, where she received a bachelor�s
degree in Management Information Systems. Scot Kennedy from Charles
River Labs� UK Preclinical site has been promoted to the role of
Chief of IT Solutions Engineering (COSE). With a proven track
record in strategic system integration, he will be instrumental in
developing, deploying, and integrating the software application set
across the whole of Charles River. Mr. Kennedy will ensure that
solutions are innovative, sustainable and implemented in line with
predicted industry growth areas and the Charles River business
strategy. Mr. Kennedy has been with Charles River for sixteen years
in various leadership roles within the IT organization. Before
assuming the COSE position, he served as the head of IT for
Preclinical Services in Edinburgh, and for Clinical Services in all
of Europe. He holds an undergraduate degree in Physics and
post-graduate degree in Information Technologies from Glasgow
University. �Both Ms. Cotti and Mr. Kennedy bring a diverse set of
experiences to bear upon Charles River Laboratories. Their years of
experience in technology coupled with a firm understanding of the
biopharma industry will enable Charles River to streamline its
information supply chain, while providing customers with a seamless
experience around data and information, the lifeblood of life
sciences�, said Chief Information Officer (CIO) Nick Ventresca in
welcoming the latest additions to Charles River�s senior
Information Technology team. About Charles River Laboratories
Charles River Laboratories based in Wilmington, Massachusetts,
partners with global pharmaceutical and biotechnology companies,
government agencies and leading academic institutions to advance
the drug discovery and development process, bringing drugs to
market faster and more efficiently. Charles River�s 7,500 employees
serve clients worldwide. For more information on Charles River,
visit our website at www.criver.com. (NYSE:CRL) Charles River
Laboratories, a leading contract research organization worldwide,
is dramatically enhancing its technological capabilities across its
entire business. In the life sciences industry which is driven by
information, Charles River is implementing advanced IT solutions
that will harness the cumulative power of its diversity of sites
through the harmonization of data. These enhanced solutions will
yield many benefits to the Company's pharmaceutical, biotech
academic and government customers. Streamlined global resource
planning will maintain consistent quality and scheduling. Increased
collaboration among sites will provide customers with Charles
River's vast breadth of global business offerings - from drug
discovery through market approval. Further, customers will find
self-service access to study data, analysis tools, reporting
engines and more through the use of customized portals. To ensure a
seamless integration of these improvements, Charles River Labs has
established two global positions that are key to this
transformation. Shanna Cotti has assumed responsibilities as Chief
Technology Officer (CTO). Ms. Cotti will be re-architecting the
infrastructure, technological environment and data integration of
these global IT initiatives. She will be responsible for the
creation, communication and dissemination of both near-term and
visionary architectural planning across Charles River Labs. Ms.
Cotti brings to Charles River an abundance of leading edge IT
expertise. Prior to joining the Company, she was a senior
consultant for Microsoft Corporation, where she led the creation
and subsequent deployment of enterprise-wide technical architecture
strategies for Fortune 500 companies. She has consulted and advised
on IT strategy for global enterprises across many industries,
including consumer goods, manufacturing, and life sciences, where
she has led the architecture and deployment of global information
management and collaboration systems. Ms. Cotti is a Pennsylvania
State University graduate of The Behrend College, where she
received a bachelor's degree in Management Information Systems.
Scot Kennedy from Charles River Labs' UK Preclinical site has been
promoted to the role of Chief of IT Solutions Engineering (COSE).
With a proven track record in strategic system integration, he will
be instrumental in developing, deploying, and integrating the
software application set across the whole of Charles River. Mr.
Kennedy will ensure that solutions are innovative, sustainable and
implemented in line with predicted industry growth areas and the
Charles River business strategy. Mr. Kennedy has been with Charles
River for sixteen years in various leadership roles within the IT
organization. Before assuming the COSE position, he served as the
head of IT for Preclinical Services in Edinburgh, and for Clinical
Services in all of Europe. He holds an undergraduate degree in
Physics and post-graduate degree in Information Technologies from
Glasgow University. "Both Ms. Cotti and Mr. Kennedy bring a diverse
set of experiences to bear upon Charles River Laboratories. Their
years of experience in technology coupled with a firm understanding
of the biopharma industry will enable Charles River to streamline
its information supply chain, while providing customers with a
seamless experience around data and information, the lifeblood of
life sciences", said Chief Information Officer (CIO) Nick Ventresca
in welcoming the latest additions to Charles River's senior
Information Technology team. About Charles River Laboratories
Charles River Laboratories based in Wilmington, Massachusetts,
partners with global pharmaceutical and biotechnology companies,
government agencies and leading academic institutions to advance
the drug discovery and development process, bringing drugs to
market faster and more efficiently. Charles River's 7,500 employees
serve clients worldwide. For more information on Charles River,
visit our website at www.criver.com.
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jul 2023 to Jul 2024